Filing Details

Accession Number:
0001209191-20-037001
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-06-16 16:53:55
Reporting Period:
2020-06-15
Accepted Time:
2020-06-16 16:53:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1556263 Syros Pharmaceuticals Inc. SYRS () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1490283 A Richard Young C/O Syros Pharmaceuticals, Inc.
35 Cambridgepark Drive
Cambridge MA 02140
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-06-15 5,990 $8.75 359,161 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.